Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewCell biologyHematology Open Access | 10.1172/JCI183761

Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress

Nan Zhang,1 Qian Wang,1 Guopeng Chen,1 Li Liu,1 Zhiying Wang,2 Linlu Ma,1 Yuxing Liang,1 Jinxian Wu,1 Xinqi Li,1 Xiaoyan Liu,1 and Fuling Zhou1

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Zhang, N. in: PubMed | Google Scholar |

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Wang, Q. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Chen, G. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Liu, L. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Wang, Z. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Ma, L. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Liang, Y. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Wu, J. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Li, X. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Liu, X. in: PubMed | Google Scholar

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2College of Chemistry and Molecular Sciences, Wuhan university, Wuhan, China

Find articles by Zhou, F. in: PubMed | Google Scholar

Published August 5, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI183761.
Copyright © 2025, Zhang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 5, 2025 - Version history
View PDF
Abstract

Acute myeloid leukemia (AML) is the most common hematological malignancy. Leukemia stem cells exhibit high levels of oxidative stress, with reactive oxygen species (ROS) being the primary products of this stress, inducing the expression of Jab1. Previous studies have demonstrated that Jab1, as a transcriptional coactivator of c-JUN, promotes the malignant progression of AML under oxidative stress. However, its role in immune evasion is still under investigation. Here, we observed that knocking out Jab1 reduced the expression of immune checkpoints in vivo, effectively overcame the immune evasion of AML. Interestingly, the deletion of Jab1 had no impact on the maturation of normal hematopoietic cells in mice. Mechanistically, Jab1 directly activated IGF2BP3 by driving the transcription factor c-JUN, consequently modulated the m6A modification of LILRB4 mRNA and promoted immune evasion in AML. Finally, CSN5i-3 effectively disrupted the signaling pathway mediated by Jab1, thereby restoring cellular immune surveillance and halting the progression of AML. Thus, our results highlight the functional role of Jab1 in supporting AML survival and support the development of targeted therapeutic strategies.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (August 5, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts